Literature DB >> 15816562

Human sarcoma cell lines MES-SA and MES-SA/Dx5 as a model for multidrug resistance modulators screening.

Olga Wesolowska1, Maria Paprocka, Joanna Kozlak, Noboru Motohashi, Danuta Dus, Krystyna Michalak.   

Abstract

The choice of cell lines for multidrug resistance (MDR) modulators screening may affect the results obtained. Screening is most often performed in model systems which employ cell lines derived from haematological malignancies. Cell lines originating from solid tumours are far less popular. In the present work, we aimed to test the usefulness of the drug-sensitive human sarcoma cell line MES-SA, and its multidrug-resistant counterpart MES-SA/Dx5, as a model system for modulators' anti-MDR potency evaluation. Overexpression of P-glycoprotein in the resistant but not in the sensitive cell line was confirmed by flow cytometry and confocal microscopy. Flow cytometry demonstrated that verapamil and trifluoperazine reduced MDR in MES-SA/Dx5 cells as assessed by the rhodamine 123 accumulation test. Both modulators also restored in MES-SA/Dx5 cells the drug accumulation pattern typical for sensitive cells, as judged by confocal microscopy. We conclude that the MES-SA and MES-SA/Dx5 cell line pair constitute a good model for MDR modulators study.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15816562

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  Distinct N-glycan glycosylation of P-glycoprotein isolated from the human uterine sarcoma cell line MES-SA/Dx5.

Authors:  D A Greer; S Ivey
Journal:  Biochim Biophys Acta       Date:  2007-07-19

2.  Non-thermal atmospheric pressure plasma preferentially induces apoptosis in p53-mutated cancer cells by activating ROS stress-response pathways.

Authors:  Yonghao Ma; Chang Seung Ha; Seok Won Hwang; Hae June Lee; Gyoo Cheon Kim; Kyo-Won Lee; Kiwon Song
Journal:  PLoS One       Date:  2014-04-23       Impact factor: 3.240

Review 3.  Research Progress in the Modification of Quercetin Leading to Anticancer Agents.

Authors:  Alessandro Massi; Olga Bortolini; Daniele Ragno; Tatiana Bernardi; Gianni Sacchetti; Massimo Tacchini; Carmela De Risi
Journal:  Molecules       Date:  2017-07-29       Impact factor: 4.411

4.  Identification of a lathyrane-type diterpenoid EM-E-11-4 as a novel paclitaxel resistance reversing agent with multiple mechanisms of action.

Authors:  Qian Liu; Pei Cai; Siwei Guo; Jiangong Shi; Hua Sun
Journal:  Aging (Albany NY)       Date:  2020-02-28       Impact factor: 5.682

5.  Preclinical optimization of Ly6E-targeted ADCs for increased durability and efficacy of anti-tumor response.

Authors:  Josefa Dela Cruz Chuh; MaryAnn Go; Yvonne Chen; Jun Guo; Hanine Rafidi; Danielle Mandikian; Yonglian Sun; Zhonghua Lin; Kellen Schneider; Pamela Zhang; Rajesh Vij; Danielle Sharpnack; Pamela Chan; Cecile de la Cruz; Jack Sadowsky; Dhaya Seshasayee; James T Koerber; Thomas H Pillow; Gail D Phillips; Rebecca K Rowntree; C Andrew Boswell; Katherine R Kozak; Andrew G Polson; Paul Polakis; Shang-Fan Yu; Peter S Dragovich; Nicholas J Agard
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

6.  Efficient Synthesis of Acylated, Dialkyl α-Hydroxy-Benzylphosphonates and Their Anticancer Activity.

Authors:  Petra R Varga; Alexandra Belovics; Péter Bagi; Szilárd Tóth; Gergely Szakács; Szilvia Bősze; Rita Szabó; László Drahos; György Keglevich
Journal:  Molecules       Date:  2022-03-23       Impact factor: 4.411

7.  Essential Oils, Pituranthos chloranthus and Teucrium ramosissimum, Chemosensitize Resistant Human Uterine Sarcoma MES-SA/Dx5 Cells to Doxorubicin by Inducing Apoptosis and Targeting P-Glycoprotein.

Authors:  Aida Lahmar; Aline Mathey; Virginie Aires; Dorra Elgueder; Anne Vejux; Rihab Khlifi; Fairouz Sioud; Leila Chekir-Ghedira; Dominique Delmas
Journal:  Nutrients       Date:  2021-05-19       Impact factor: 5.717

8.  High CD49f expression is associated with osteosarcoma tumor progression: a study using patient-derived primary cell cultures.

Authors:  Patrice Penfornis; David Z Cai; Michael R Harris; Ryan Walker; David Licini; Joseph D A Fernandes; Griffin Orr; Tejaswi Koganti; Chindo Hicks; Spandana Induru; Mark S Meyer; Rama Khokha; Jennifer Barr; Radhika R Pochampally
Journal:  Cancer Med       Date:  2014-05-07       Impact factor: 4.452

9.  N-alkylated isatins evade P-gp mediated efflux and retain potency in MDR cancer cell lines.

Authors:  Kara L Vine; Lisa Belfiore; Luke Jones; Julie M Locke; Samantha Wade; Elahe Minaei; Marie Ranson
Journal:  Heliyon       Date:  2016-01-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.